Alliance Pharma plc (LON:APH – Get Free Report)’s share price reached a new 52-week high on Wednesday . The company traded as high as GBX 50.26 ($0.64) and last traded at GBX 48.75 ($0.62), with a volume of 904707 shares trading hands. The stock had previously closed at GBX 49.55 ($0.63).
Alliance Pharma Trading Down 1.6 %
The business’s 50-day moving average is GBX 45.33 and its two-hundred day moving average is GBX 40.55. The firm has a market cap of £263.53 million, a P/E ratio of -825.83, a P/E/G ratio of 1.04 and a beta of 0.67. The company has a debt-to-equity ratio of 47.46, a current ratio of 2.93 and a quick ratio of 1.42.
Alliance Pharma Company Profile
Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.
Read More
- Five stocks we like better than Alliance Pharma
- 3 Tickers Leading a Meme Stock Revival
- The Great CPU Race: AMD and Intel Battle for Dominance
- Airline Stocks – Top Airline Stocks to Buy Now
- GameStop Turns a Profit: So What? It’s Still Not Worth Investing
- What is the FTSE 100 index?
- C3.ai Stock Surges on Strong Sales Despite Profit Concerns
Receive News & Ratings for Alliance Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alliance Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
